This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Nikolche Gjorevski
Principal Scientist and Lead at Roche


Nikolche completed his doctoral degree in the laboratory of Celeste Nelson at Princeton University. He then joined the laboratory of Matthias Lutolf at EPFL as a postdoc, using synthetic biomaterials and microfabrication to study and control epithelial organoid formation. In 2018, Nikolche joined Roche, where, as a scientist and Lab Head, he focused on establishing patient-derived organoids and microphysiological systems as platforms for preclinical safety assessment. In 2021, Nikolche joined the Roche Institute for Translational Bioengineering, where he leads a team focused on increasing the (patho)physiological relevance and translational impact of organoids.

Agenda Sessions

  • Engineered Immunocompetent Models of the Human Intestine: Applications in TCB Safety Profiling and Beyond


Speakers at this event